临床QC经理
艾棣维欣(苏州)生物制药有限公司
- 公司规模:150-500人
- 公司性质:民营公司
- 公司行业:制药/生物工程
职位信息
- 发布日期:2021-01-05
- 工作地点:苏州-工业园区
- 招聘人数:若干人
- 工作经验:3-4年经验
- 学历要求:本科
- 职位月薪:1.5-3万/月
- 职位类别:临床研究员
职位描述
岗位职责:
1、维护更新临床开发部SOP和相关的工作流程文件,并对批准的SOPs进行培训工作;
2、参与内部稽查,书写稽查报告,追踪稽查问题的整改落实;
3、参与或负责供应商、临床现场或合作方的筛选评估,及进行中的定期稽查,以及问题追踪;
4、审阅稽查报告及相关文件;
5、参与部门培训体系的建立,为团队提供培训支持。
任职要求:
1、临床医学、药理学、护理学、卫生护理或其他相关专业,本科及以上学历;
2、3年以上CRA或项目管理经验,熟悉GCP及临床试验相关法律法规,有疫苗、肿瘤临床经验优先;
3、能适应出差;
4、能承受工作压力、良好的沟通能力及团队合作精神;
5、英文4级及以上,具备基本的英文阅读、书写能力。
6、本岗位可base在南京、苏州、上海,优先苏州。
公司介绍
艾棣维欣(苏州)生物制药有限公司位于苏州工业园区,是研发创新疫苗的生物技术公司。公司专注研究基因工程疫苗、DNA疫苗、新型疫苗佐剂技术,在国内外有系统的知识产权布局。
公司运用这些平台技术,主要进行抗病毒疫苗的研发,尤其在新型病毒性肺炎疫苗研发领域拥有国际先进技术实力。
艾棣维欣和美国INOVIO制药联合研发的新型冠状病毒DNA疫苗已在中美同步开展临床试验。艾棣维欣开发的新型呼吸道合胞病毒(RSV)肺炎疫苗正在海外开展临床研究,研发进展居于全球前列。
Advaccine Biopharmaceuticals Suzhou Co., Ltd. is a biotechnology company developing innovative vaccines in BioBay of Suzhou Industrial Park. The company focuses on the research of genetic engineering vaccine, DNA vaccine, innovative vaccine adjuvant technology. There is a systematic distribution of intellectual property in china and abroad.
The company uses these technologies, mainly engaged in the research and development of antiviral vaccines, especially the company’s innovated vaccine for viral pneumonia possesses the leading technology worldwide.
Clinical trials are being conducted for the COVID-19 DNA vaccine, co-developed by Advaccine and INOVIO Pharmaceuticals simultaneously in China and the United States. The company’s innovative vaccine for respiratory syncytial virus (RSV) is under clinical investigation abroad and its progress of research and development is in the forefront of the world.
公司运用这些平台技术,主要进行抗病毒疫苗的研发,尤其在新型病毒性肺炎疫苗研发领域拥有国际先进技术实力。
艾棣维欣和美国INOVIO制药联合研发的新型冠状病毒DNA疫苗已在中美同步开展临床试验。艾棣维欣开发的新型呼吸道合胞病毒(RSV)肺炎疫苗正在海外开展临床研究,研发进展居于全球前列。
Advaccine Biopharmaceuticals Suzhou Co., Ltd. is a biotechnology company developing innovative vaccines in BioBay of Suzhou Industrial Park. The company focuses on the research of genetic engineering vaccine, DNA vaccine, innovative vaccine adjuvant technology. There is a systematic distribution of intellectual property in china and abroad.
The company uses these technologies, mainly engaged in the research and development of antiviral vaccines, especially the company’s innovated vaccine for viral pneumonia possesses the leading technology worldwide.
Clinical trials are being conducted for the COVID-19 DNA vaccine, co-developed by Advaccine and INOVIO Pharmaceuticals simultaneously in China and the United States. The company’s innovative vaccine for respiratory syncytial virus (RSV) is under clinical investigation abroad and its progress of research and development is in the forefront of the world.
联系方式
- 公司地址:地址:span星湖街218号生物纳米园B1